在乳腺癌腋窝淋巴结清扫术中应用腋窝反向映像技术的可行性与肿瘤学安全性

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (2541 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To research the feasibility of axillary reverse mapping (ARM) in axillary lymph node dissection for breast cancer patients and the safety of the tumor. Methods: Thirty patients with modified radical mastectomy for breast cancer were treated with methylene blue solution for lymph node biopsy. The axillary lymph node dissection was performed and the lymph nodes were removed for histopathological examination. Results: The 30 patients with breast cancer, and 21 patients had successfully detected blue-stained lymph nodes, 9 cases had failed, and 25 had blue-stained lymph nodes. No obvious cancer metastasis was found. Excision of lymph nodes in 21 cases, no case of upper limb lymph node edema. Conclusion: It is feasible to carry out ARM using methylene blue solution injection method for lymph node tracing and localization, and the oncologically burden is safe.

Key words： axillary reverse mapping breast neoplasms upper extremity edema lymph node excision oncological safety

Received: 16 February 2017

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

URL:

https://xb.wmu.edu.cn/EN/ OR https://xb.wmu.edu.cn/EN/Y2017/V47/I11/801

[1] TUMMEL E, OCHOA D, KOROURIAN S, et al. Does axillary reverse mapping prevent lymphedema after lymphade-nectomy[J]. Ann Surg, 2017; 265(5): 987-992.
[2] JAGSI R, CHADHA M, MONI J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial[J]. J Clin Oncol, 2014, 32(32): 3600-3606.
[3] WILLIAMS A F, FRANKS P J, MOFFATT C J. Lymphoedema: estimating the size of the problem[J]. Palliat Med, 2005, 19(4): 300-313.
[4] MANSEL R E, FALLOWFIELD L, KISSIN M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial[J]. J Nat l Cancer Inst, 2006, 98(9): 599-609.
[5] BLANCHARD D K, DONOHUE J H, REYNOLDS C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer[J]. Arch Surg, 2003, 138(5): 482-487.
[6] NOGUCHI M, YAGASAKI R, KAWAHARA F, et al. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer[J]. Int Surg, 1997, 82(3): 289-294.
[7] MORTON D L, WEN D R, WONG J H, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma[J]. Arch Surg, 1992, 127(4): 392-399.
[8] HSUEH E C, GIULIANO A E. Sentinel lymph node technique for staging of breast cancer[J]. Oncologist, 1998; 3(3): 165-170.
[9] THOMPSON M, KOROURIN S, HENRY-TILLMAN R,
et al. Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation[J]. Ann Surg Oncol, 2007, 14(6): 1890-1895.
[10] BONETI C, KOROURIAN S, BLAND K, et al. Axillary reverse mapping:mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy[J]. J Am Coll Surg, 2008, 206(5): 1038-1042.
[11] BONETI C, KOROURIAN S, DIAZ Z, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymph-adenectomy[J]. Am J Surg, 2009, 198(4): 482-487.
[12] HAN J W, SEO Y J, CHOI J E, et al. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer[J]. J Breast Cancer, 2012, 15(1): 91-97.
[13] AHMED R L, SCHMITZ K H, PRIZMENT A E, et al. Risk factors for lymphedema in breast cancer survivors, the lowa Women’s Health Study[J]. Breast Cancer Res Treat, 2011, 130(3): 981-991.
[14] KWAN M L, DARBIBIAN J, SCHMITZ K H, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study[J]. Arch Surg, 2010, 145(11): 1055-1063.
[15] SHAH C, WILKINSON J B, BASCHNAGEL A, et al. Factors associated with the development of breast cancer-related lymphedema after whole breast irradiation[J]. Int J Radiat Oncol Biol Phys, 2012, 83(4): 1095-1100.
[16] HAYES S B, FREEDMAN G M, LI T, et al. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?[J]. Int J Radiat Oncol Biol Phys, 2008, 72(5): 1449-1455.
[17] PETREK J A, SENIE R T, PETERS M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after di-agnosis[J]. Cancer, 2001, 92(6): 1368-1377.
[18] KHAN S A. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept[J]. J Clin Oncol, 2009, 27(33): 5494-5496.
[19] 雷睿文, 欧林洋, 黄湛,等. 逆行腋窝淋巴结示踪术对预防乳腺癌术后上肢淋巴水肿的作用[J]. 广东医学, 2014, 35 (5): 704-707.
[20] KUMAR K S, HEMANTH G N, PANJWANI P K, et al. Feasibility of axillary reverse mapping and clinicopathological features predicting ARM node metastasis in breast cancer-a pilot study[J]. J Surg Oncol, 2017, 8(2): 119-122.
[21] RUBIO I T, CEBRECOS I, PEG V, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast can-cer[J]. J Surg Oncol, 2012, 106(1): 89-93.
[22] NGUI N K, FRENCH J, KILDY C J, et al. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe[J]. J Surg Oncol, 2016, 113(7): 726-731.
[23] GANDHI S J, SATISH C, SUNDARAM P S, et al. Feasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast:A concept toward preventing lymphedema [J]. Indian J Nucl Med, 2016, 31(1): 9-13.
[24] BEEK M A, GOBARDHAN P D, KLOMPENHOUWER E G,
et al. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients[J]. Eur J Surg Oncol, 2015, 41(1): 59-63.
[25] OCHOA D, KORAURIAN S, BOETI C, et al. Axillary reverse mapping: five-year experience[J]. Surgery, 2014, 156 (5): 1261-1268.
[26] TAUSCH C, BAEGE A, DIETRICH D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients[J]. Eur J Surg Oncol, 2013, 39(8): 880-886.
[27] GEBRUERS N, TJALMA W A. Clinical feasibility of axillary reverse mapping and its influence on breast cancer related lymphedema: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 200: 117-122.
[28] PARKS R M, CHEUNG K L. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy-A systematic review of the literature and necessity of a randomised study[J]. Breast, 2017, 33: 57-70.